Biomed Industries, Inc. Advances Dual-Track Obesity Therapy Strategy with Near-Term Revenue and NA-931 Phase 3 Launch | Afio mai! | Slzii.com | Tala Fou, su'esu'e ile upegatafa'ilagi, feso'ota'iga fa'aagafesootai, ta'aloga, fa'afiafiaga, so'oga & mea faigaluega

utaina

Slzii.com Saili

Tala Fou

E sili atu Tala Fou >>

Slzii.com Su'e i luga ole laiga

Slzii.com Social Network

Android app

Social Network >>

O au mea na e fai?

0.025635004043579

Afio mai!
Afio mai!

Tala Fou, su'esu'e ile upegatafa'ilagi, feso'ota'iga fa'aagafesootai, ta'aloga, fa'afiafiaga, so'oga & mea faigaluega
Biomed Industries, Inc. Advances Dual-Track Obesity Therapy Strategy with Near-Term Revenue from Bioxentra Life Sciences, Inc. and NA-931 Ph...
Social Network, luga o le initaneti, talatalanoaga, fai uo i luga o le initaneti, lafoina vitio, lafo savali, faʻafesoʻotaʻi, fesootai